Year archive

Camurus — 2026 filings

All 9 regulatory filings released by Camurus (CAMX) in 2026, sourced directly from the official regulator.

9 Filings

2026 Period

2026 filings (9)

Filing	Released	Lang
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-05-12	Swedish
Interim / Quarterly Report 2026 Interim / Quarterly Report Q1 2026	2026-05-12	English
Annual Report (ESEF) 2025 Annual Report (ESEF) FY 2025	2026-04-29	Swedish
Förändring av antalet aktier och röster i Camurus Share Issue/Capital Change	2026-03-31	Swedish
Change in number of shares and votes in Camurus Share Issue/Capital Change	2026-03-31	English
Interim / Quarterly Report 2025 Interim / Quarterly Report Q4 2025	2026-02-12	Swedish
Earnings Release 2025 Earnings Release Q4 2025	2026-02-12	English
Camurus ansökan om marknadsgodkännande av Oclaiz™ för behandling av akromegali accepterad för granskning av FDA Regulatory Filings	2026-01-09	Swedish
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly Regulatory Filings	2026-01-09	English

Filings by year

2026 9 filings
2025 39 filings
2024 37 filings
2023 32 filings
2022 31 filings
2021 43 filings
2020 39 filings
2019 45 filings
2018 41 filings
2017 21 filings
2016 34 filings
2015 8 filings